149 related articles for article (PubMed ID: 34693506)
21. The Long Non-Coding RNA TP73-AS1 Interacted With miR-142 to Modulate Brain Glioma Growth Through HMGB1/RAGE Pathway.
Zhang R; Jin H; Lou F
J Cell Biochem; 2018 Apr; 119(4):3007-3016. PubMed ID: 28379612
[TBL] [Abstract][Full Text] [Related]
22. Long non-coding RNA PAXIP1-AS1 facilitates cell invasion and angiogenesis of glioma by recruiting transcription factor ETS1 to upregulate KIF14 expression.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Yu H; Qi L
J Exp Clin Cancer Res; 2019 Dec; 38(1):486. PubMed ID: 31823805
[TBL] [Abstract][Full Text] [Related]
23. Survival analysis of immune-related lncRNA in low-grade glioma.
Li X; Meng Y
BMC Cancer; 2019 Aug; 19(1):813. PubMed ID: 31419958
[TBL] [Abstract][Full Text] [Related]
24. Long non coding RNA SLC26A4-AS1 exerts antiangiogenic effects in human glioma by upregulating NPTX1 via NFKB1 transcriptional factor.
Li H; Yan R; Chen W; Ding X; Liu J; Chen G; Zhao Q; Tang Y; Lv S; Liu S; Yu Y
FEBS J; 2021 Jan; 288(1):212-228. PubMed ID: 32255252
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and clinicopathological significance of long non-coding RNA in glioma.
Li J; Liang R; Song C; Xiang Y; Liu Y
Neurosurg Rev; 2020 Feb; 43(1):1-8. PubMed ID: 29564570
[TBL] [Abstract][Full Text] [Related]
26. Expression of long non-coding RNA MAGI2‑AS3 in human gliomas and its prognostic significance.
Chen XD; Zhu MX; Wang SJ
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3455-3460. PubMed ID: 31081100
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
Liu L; Li X; Shi Y; Chen H
Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
[TBL] [Abstract][Full Text] [Related]
28. Long noncoding FOXD2-AS1 is activated by CREB1 and promotes cell proliferation and metastasis in glioma by sponging miR-185 through targeting AKT1.
Dong H; Cao W; Xue J
Biochem Biophys Res Commun; 2019 Jan; 508(4):1074-1081. PubMed ID: 30553445
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA CASC2 suppresses malignancy in human gliomas by miR-21.
Wang P; Liu YH; Yao YL; Li Z; Li ZQ; Ma J; Xue YX
Cell Signal; 2015 Feb; 27(2):275-82. PubMed ID: 25446261
[TBL] [Abstract][Full Text] [Related]
30. An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells.
Wang Q; Zhuang ZW; Cheng YM; Ma JQ; Xu SY; Zhong CL; Zhang KM
IUBMB Life; 2019 Jan; 71(1):93-104. PubMed ID: 30290058
[TBL] [Abstract][Full Text] [Related]
31. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
Xiao S; Wang R; Wu X; Liu W; Ma S
DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
[TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA AGAP2-AS1 promotes the proliferation of glioma cells by sponging miR-15a/b-5p to upregulate the expression of HDGF and activating Wnt/β-catenin signaling pathway.
Zheng Y; Lu S; Xu Y; Zheng J
Int J Biol Macromol; 2019 May; 128():521-530. PubMed ID: 30684575
[TBL] [Abstract][Full Text] [Related]
33. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNA HOXA11-AS Functions as miRNA Sponge to Promote the Glioma Tumorigenesis Through Targeting miR-140-5p.
Cui Y; Yi L; Zhao JZ; Jiang YG
DNA Cell Biol; 2017 Oct; 36(10):822-828. PubMed ID: 28832185
[TBL] [Abstract][Full Text] [Related]
35. Highly expressed lncRNA CCND2-AS1 promotes glioma cell proliferation through Wnt/β-catenin signaling.
Zhang H; Wei DL; Wan L; Yan SF; Sun YH
Biochem Biophys Res Commun; 2017 Jan; 482(4):1219-1225. PubMed ID: 27923660
[TBL] [Abstract][Full Text] [Related]
36. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.
Guo H; Hu G; Yang Q; Zhang P; Kuang W; Zhu X; Wu L
Oncotarget; 2016 Dec; 7(49):81806-81814. PubMed ID: 27833083
[TBL] [Abstract][Full Text] [Related]
37. Up‑regulation of lncRNA PXN-AS1-L is associated with unfavorable prognosis in patients suffering from glioma.
Shang F; Du SW; Ma XL
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8950-8955. PubMed ID: 31696482
[TBL] [Abstract][Full Text] [Related]
38. LncRNA TSLC1-AS1 is a novel tumor suppressor in glioma.
Qin X; Yao J; Geng P; Fu X; Xue J; Zhang Z
Int J Clin Exp Pathol; 2014; 7(6):3065-72. PubMed ID: 25031725
[TBL] [Abstract][Full Text] [Related]
39. Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
Maimaiti A; Jiang L; Wang X; Shi X; Pei Y; Hao Y; Paerhati H; Zibibula Y; Abudujielili A; Kasimu M
Clin Neurol Neurosurg; 2021 Feb; 201():106464. PubMed ID: 33454543
[TBL] [Abstract][Full Text] [Related]
40. Upregulated lncRNA ADAMTS9-AS2 suppresses progression of lung cancer through inhibition of miR-223-3p and promotion of TGFBR3.
Liu C; Yang Z; Deng Z; Zhou Y; Gong Q; Zhao R; Chen T
IUBMB Life; 2018 Jun; 70(6):536-546. PubMed ID: 29707897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
